Search

everythinglearnresearchcommunity

for

Search:↓

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Air pollution harms skin health and can worsen skin diseases.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Key genes and pathways influence cashmere production in goats.

The new microneedle system promotes hair growth by improving the hair follicle environment.

New hair loss treatments like stem cells and gene therapy show promise but need more research for safety and effectiveness.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Broccoli sprout extract may help regrow hair by improving hormone metabolism.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Non-liganded Vitamin D Receptor is crucial for healthy skin and hair.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Blocking testosterone speeds up wound healing in males.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.